Terray is a biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small molecule therapeutics. The company explores molecules and targets with a sophisticated integration of ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology. Terray's platform uniquely blends experimentation and computation to deliver on the promise of generative AI for small molecule discovery-finding solutions to the toughest therapeutic challenges.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/18/24 | $120,000,000 | Series B |
Alexandria Venture Investments Bedford Ridge  Digitalis Ventures Goldcrest Capital Madrona Ventures Maverick Capital NVentures Two Sigma Ventures XTX Ventures | undisclosed |
